Literature DB >> 23754647

Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.

S Mine1, T Sano, N Hiki, K Yamada, T Kosuga, S Nunobe, T Yamaguchi.   

Abstract

BACKGROUND: A gross proximal oesophageal margin greater than 5 cm is considered to be necessary for curative surgery of adenocarcinoma of the oesophagogastric junction. This study investigated whether a shorter proximal margin might suffice in the context of total gastrectomy for Siewert type II and III tumours.
METHODS: The gross proximal margin was measured on stretched specimens just after resection. Relationships between gross proximal margin lengths and clinicopathological features were investigated in patients with Siewert type II and III adenocarcinoma of the oesophagogastric junction treated by R0-1 surgical resection. For survival analyses, only patients who had undergone R0 resection for pathological (p) T2-4N0-3M0 tumour via a transhiatal approach were evaluated.
RESULTS: Of the 140 patients, 120 had a total gastrectomy. Two patients (1·4 per cent) had histologically positive proximal margins and another two (1·4 per cent) developed anastomotic recurrence. Of 100 patients with pT2-4N0-3M0 tumours who underwent gastrectomy via a transhiatal approach, those with gross proximal margins larger than 20 mm appeared to have better survival than those with shorter margins (P = 0·027). Multivariable analysis demonstrated that a gross proximal margin of 20 mm or less was an independent prognostic factor (hazard ratio (HR) 3·56, 95 per cent confidence interval 1·39 to 9·14; P = 0·008), as was pathological node status (HR 1·76, 1·08 to 2·86; P = 0·024).
CONCLUSION: Gross proximal margin lengths of more than 20 mm in resected specimens seem satisfactory for patients with type II and III adenocarcinoma of the oesophagogastric junction treated by transhiatal gastrectomy.
© 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23754647     DOI: 10.1002/bjs.9170

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

1.  [New S3 guideline for esophageal cancer : Important surgical aspects].

Authors:  A H Hölscher; M Stahl; H Messmann; M Stuschke; H J Meyer; R Porschen
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

Review 2.  Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.

Authors:  Andrew M Brown; Danica N Giugliano; Adam C Berger; Michael J Pucci; Francesco Palazzo
Journal:  Langenbecks Arch Surg       Date:  2017-08-12       Impact factor: 3.445

Review 3.  Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.

Authors:  Arnulf H Hölscher; Simon Law
Journal:  Gastric Cancer       Date:  2019-11-06       Impact factor: 7.370

Review 4.  Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Authors:  Erman Aytaç; Fatih Aslan; Bahattin Çicek; Sibel Erdamar; Bengi Gürses; Koray Güven; Okan Falay; Tayfun Karahasanoğlu; Fatih Selçukbiricik; Uğur Selek; Banu Atalar; Emre Balık; Nurdan Tözün; İzzet Rozanes; Ali Arıcan; İsmail Hamzaoğlu; Bilgi Baca; Nil Molinas Mandel; Murat Saruç; Süha Göksel; Gökhan Demir; Fulya Ağaoğlu; Cengiz Yakıcıer; Uğur Özbek; Volkan Özben; Enis Özyar; Ahmet Levent Güner; Özlem Er; Kerim Kaban; Yasemin Bölükbaşı; Dursun Buğra; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2019-07       Impact factor: 1.852

Review 5.  Current status of management of malignant disease: current management of gastric cancer.

Authors:  Roderich E Schwarz
Journal:  J Gastrointest Surg       Date:  2015-01-16       Impact factor: 3.452

Review 6.  Siewert III adenocarcinoma: treatment update.

Authors:  Alberto Di Leo; Andrea Zanoni
Journal:  Updates Surg       Date:  2017-03-16

7.  Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.

Authors:  Arnulf H Hölscher; Elfriede Bollschweiler; Ulrich K Fetzner; Benjamin Babic
Journal:  Updates Surg       Date:  2022-08-24

8.  Safety and efficacy of preoperative indocyanine green fluorescence marking in laparoscopic gastrectomy for proximal gastric and esophagogastric junction adenocarcinoma (ICG MAP study).

Authors:  Takeshi Omori; Hisashi Hara; Naoki Shinno; Masaaki Yamamoto; Takashi Kanemura; Tomohira Takeoka; Hirofumi Akita; Hiroshi Wada; Masayoshi Yasui; Chu Matsuda; Junichi Nishimura; Masayuki Ohue; Masato Sakon; Hiroshi Miyata
Journal:  Langenbecks Arch Surg       Date:  2022-10-13       Impact factor: 2.895

9.  Simple and reliable transhiatal reconstruction after laparoscopic proximal gastrectomy with lower esophagectomy for Siewert type II tumors: y-shaped overlap esophagogastric tube reconstruction.

Authors:  Shingo Kanaji; Satoshi Suzuki; Masashi Yamamoto; Kohei Tanigawa; Hitoshi Harada; Naoki Urakawa; Ryuichiro Sawada; Hironobu Goto; Hiroshi Hasegawa; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Yoshihiro Kakeji
Journal:  Langenbecks Arch Surg       Date:  2022-04-29       Impact factor: 2.895

10.  Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection.

Authors:  Hiroshi Saeki; Masayuki Watanabe; Shinji Mine; Hironobu Shigaki; Shuichiro Oya; Akiyoshi Ishiyama; Tomohiro Tsuchida; Junko Fujisaki; Hideo Baba; Yoshihiko Maehara; Takeshi Sano
Journal:  J Gastroenterol       Date:  2014-08-02       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.